… , we showed that anti-inflammatory agents yield mild cardiovascular protective effects but
result … However, further subgroup analysis demonstrated that multiple anti-inflammatory agents …

… have suggested that anti-inflammatory therapy can inhibit the atherosclerotic process, the
efficacy of anti-inflammatory therapy for patients with coronary artery disease (CAD) is still …

… Actually, at the moment, there are no robust data that show real benefits of anti-inflammatory
therapy in CAD. Some trials, furthermore, showed no benefit. Some fear that what …

… , has gained interest in vascular disease as it exerts anti-inflammatory effects via NFkB, …
C obtained from patients with coronary artery disease, acute coronary syndromes, and renal …

… In conclusion, the anti-inflammatory therapy of targeting the IL-1beta innate immunity
pathway with canakinumab at a dosage of 150 mg every three months significantly reduced the …

… with anti-inflammatory therapy versus standard of care alone. Anti-inflammatory therapy …
First, although we included all patients with coronary artery disease, they range in severity …

… the effect of statin therapy on patients with stable coronary artery disease, and their results
have shown a positive correlation between the therapy and the disease outcome. A study by …

… in the anti-inflammatory treatment of patients with rheumatic joint disease (predominantly …
The trial studied whether low-dose methotrexate reduced cardiovascular risk with a primary …

… therapy emerged as an innovative and promising approach in atherosclerotic cardiovascular
disease. In … trials which explored the anti-inflammatory approach in coronary artery disease. …

… The LoDoCo (low-dose colchicine) trial was a prospective, randomized trial, which evaluated
532 patients with stable coronary artery disease (CAD), of which 282 were treated with …